Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (20)
NICE advice (1)
Quality standard (1)
Guidance programme
Guidance programme
Clinical guidelines (2)
Diagnostics guidance (2)
Interventional procedures guidance (1)
NICE guidelines (2)
Technology appraisal guidance (15)
Apply filters
Showing 1 to 10 of 20
Sort by
Date
Title
Apply sorting
colorectal cancer
Remove colorectal cancer filter
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Pembrolizumab for previously treated endometrial, biliary,
colorectal
, gastric or small intestine
cancer
with high microsatellite instability or mismatch repair deficiency
TA914
20 September 2023
20 September 2023
Quantitative faecal immunochemical testing to guide
colorectal cancer
pathway referral in primary care
DG56
24 August 2023
24 August 2023
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent
colorectal cancer
IPG763
6 June 2023
6 June 2023
Regorafenib for previously treated metastatic
colorectal cancer
TA866
8 February 2023
8 February 2023
Colorectal cancer
prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas
CG118
23 March 2011
20 September 2022
Colorectal cancer
NG151
29 January 2020
15 December 2021
Nivolumab with ipilimumab for previously treated metastatic
colorectal cancer
with high microsatellite instability or mismatch repair deficiency
TA716
28 July 2021
28 July 2021
Pembrolizumab for untreated metastatic
colorectal cancer
with high microsatellite instability or mismatch repair deficiency
TA709
23 June 2021
23 June 2021
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic
colorectal cancer
TA668
6 January 2021
6 January 2021
Cetuximab and panitumumab for previously untreated metastatic
colorectal cancer
TA439
29 March 2017
25 September 2017
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top